StudyRareStudyRare

Cell Biology

9 topics

Overview

Cell biology gives you the mechanistic vocabulary you need to reason about chromosome abnormalities, syndromic overlap, and "why does this same gene show up in three unrelated diseases?" The chapter is built around four lenses, each of which surfaces a different family of disorders:

  • Cell division: how chromosomes are partitioned during mitosis and meiosis. Errors produce the entire family of numerical chromosome abnormalities (trisomies, monosomies, mosaicism).
  • Chromosome organization: how DNA is packaged, named, and re-arranged. Errors produce structural rearrangements (translocations, inversions, deletions).
  • Organelles & cellular architecture: how disorders cluster around the organelle whose function they disrupt. Lysosomal storage, peroxisomal disorders, mitochondrial disease, ciliopathies, and laminopathies are all "organelle diseases" with predictable phenotypic signatures.
  • Signaling pathways: how disparate-looking syndromes turn out to be lesions in the same pathway. The RASopathies (Noonan/NF1/Costello/CFC) and the PI3K-AKT-mTOR family (TSC/PHTS/PROS) are the canonical examples; recognizing the pathway is often more useful than memorizing every named syndrome.

Antigen Presentation & Immunogenetics

The HLA (human leukocyte antigen) locus on 6p21.3 is the most polymorphic region of the human genome and the molecular basis of cell-surface antigen presentation. It matters across three clinical domains: transplantation matching, autoimmunity risk, and pharmacogenomic prediction of severe drug hypersensitivity reactions. HLA & MHC covers the class I vs class II architecture, the core HLA-disease association table (B27, DQ2/DQ8, DR3/DR4, etc.), the pharmacogenomic HLAs that require pre-prescription testing, and the clinical uses.

Cell Division

The leaves in this section cover the cellular machinery of cell division. Meiosis and Nondisjunction is the centerpiece: it explains why aneuploidy occurs and why advanced maternal age is a risk factor. Cell Cycle gives the regulatory framework (cyclins, checkpoints, what goes wrong in cancer). Gametogenesis covers the male/female differences and where in oogenesis vs. spermatogenesis errors are most likely.

Chromosome Organization

Covers how DNA is condensed into chromosomes, the vocabulary used to describe regions and bands (connecting to the Nomenclature chapter in Laboratory), and the structural features (low-copy repeats, fragile sites) that predispose certain regions to recurrent rearrangement. This is the conceptual scaffold for understanding microdeletion/microduplication syndromes and recurrent translocations.

Organelles & Cellular Architecture

Many genetic diseases group naturally by the organelle they disrupt; recognizing the organelle behind the phenotype is one of the most useful mental moves in clinical genetics:

  • Cilia → ciliopathies (Joubert, Bardet-Biedl, Meckel-Gruber, ADPKD/ARPKD, retinitis pigmentosa, primary ciliary dyskinesia / Kartagener)
  • Mitochondria → maternally inherited mitochondrial disease (MELAS, MERRF, LHON, Leigh; covered also in Mitochondrial Inheritance under Inheritance Patterns)
  • Lysosomes → lysosomal storage disorders (Gaucher, Tay-Sachs, Fabry, Pompe, MPS family)
  • Peroxisomes → Zellweger spectrum, X-linked adrenoleukodystrophy, Refsum
  • Nuclear envelope → laminopathies (LMNA): Hutchinson-Gilford progeria, Emery-Dreifuss muscular dystrophy, dilated cardiomyopathy
  • ER / Golgi → CDG (congenital disorders of glycosylation), unfolded protein response disorders (e.g., the ZZ allele in α1-antitrypsin)

The metabolic disorders that map cleanly to an organelle (lysosomal/peroxisomal/mitochondrial) live conceptually here. The remaining inborn errors of metabolism (urea cycle, glycogen storage, fatty acid oxidation, amino acidopathies, organic acidemias) are pathway-rather-than-organelle diseases and may eventually merit their own chapter; for now they show up case-by-case in the Conditions library.

Signaling Pathways

Many syndromes that look unrelated clinically are different lesions in the same pathway. Two cassettes dominate the field:

  • RAS / MAPK: the RASopathies. NF1, Noonan, Costello, CFC, LEOPARD, Legius. Collectively the most common single-gene cause of congenital heart disease.
  • PI3K / AKT / mTOR: tuberous sclerosis (TSC), PTEN hamartoma tumor syndrome (PHTS), PIK3CA-related overgrowth spectrum (PROS) including CLOVES and megalencephaly-capillary malformation. Some are now treatable with rapamycin/everolimus.

Hedgehog, Wnt, and TGF-β signaling each anchor smaller syndrome families (Gorlin, sclerosteosis, Marfan/Loeys-Dietz); those are scattered across organ-system chapters in the Conditions library where the phenotype is most recognizable.

Key Concepts

  • Meiosis I vs. meiosis II errors: stage of nondisjunction affects the resulting karyotype and parental origin
  • Maternal age effect: why advanced maternal age increases risk for trisomies
  • Mitosis vs. meiosis: distinguishing the two types of cell division
  • Chromosome anatomy: centromeres, telomeres, p/q arms, banding, structural features that predispose to rearrangement
  • Organelle-mapped disease patterns: recognizing the organelle behind a phenotype (cilia, mito, lysosome, peroxisome)
  • Pathway-mapped syndrome families: RAS/MAPK and PI3K-AKT-mTOR as unifying frameworks